本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Iovance Biotherapeutics, Inc.

8.44
+0.38004.71%
盤後8.440.00000.00%18:36 EDT
成交量:1,190.17萬
成交額:9,954.16萬
市值:38.23億
市盈率:-11.96
高:8.48
開:8.16
低:8.03
收:8.06
52周最高:9.36
52周最低:1.76
股本:4.53億
流通股本:3.94億
量比:0.49
換手率:3.02%
股息:- -
股息率:- -
每股收益(TTM):-0.7058
每股收益(LYR):-1.0941
淨資產收益率:-40.36%
總資產收益率:-20.31%
市淨率:5.19
市盈率(LYR):-7.71

資料載入中...

2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/29

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/03

重要事件披露

Form 8-K - Current report
2026/06/18

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/18

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/10

重要事件披露

Form 8-K - Current report
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/03/20

重要事件披露

Form 8-K - Current report
2026/02/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

重要事件披露

Form 8-K - Current report
2026/01/09

重要事件披露

Form 8-K - Current report
2025/11/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report